2.41
-0.12 (-4.74%)
| Previous Close | 2.53 |
| Open | 2.50 |
| Volume | 71,517 |
| Avg. Volume (3M) | 657,176 |
| Market Cap | 86,007,840 |
| Price / Sales | 243.53 |
| Price / Book | 8.61 |
| 52 Weeks Range | |
| Earnings Date | 13 Aug 2025 - 17 Aug 2025 |
| Diluted EPS (TTM) | -0.500 |
| Total Debt/Equity (MRQ) | 2.83% |
| Current Ratio (MRQ) | 7.00 |
| Operating Cash Flow (TTM) | -12.63 M |
| Levered Free Cash Flow (TTM) | -7.96 M |
| Return on Assets (TTM) | -67.36% |
| Return on Equity (TTM) | -146.09% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Bearish |
| Medical Devices (Global) | Bearish | Bearish | |
| Stock | Monogram Technologies Inc. | Mixed | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 4.0 |
| Average | 0.38 |
|
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 33.52% |
| % Held by Institutions | 5.15% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Focus Partners Advisor Solutions, Llc | 31 Mar 2025 | 213,678 |
| New Harbor Financial Group, Llc | 31 Mar 2025 | 29,348 |
| Orion Portfolio Solutions, Llc | 31 Mar 2025 | 25,000 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 14 May 2025 | Announcement | Monogram Technologies Reports First Quarter 2025 Financial Results |
| 06 May 2025 | Announcement | Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time |
| 29 Apr 2025 | Announcement | Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India |
| 29 Apr 2025 | Announcement | CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |